Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study - Top-Institutions - MDSpire

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

  • By

  • Bassam Abdul Rasool Hassan

  • Ali Haider Mohammed

  • Khalis Mohamed

  • Vladimir Yu. Startsev

  • Chema Drira

  • Omar Hamdy

  • Miada Mohamed Fahmi Elmetwaly

  • Said Nabil

  • Shamma Alshehhi

  • Gamil Othman

  • Hamoud H. Y. Al-Hussaini

  • Ahmed Zuhair Abdulhameed Alsammarraie

  • Arooj Abid

  • Nada M. Kassem

  • Sami El Khatib

  • Souheil Hallit

  • Diana Malaeb

  • Hassan Hosseini

  • June 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Duke University Medical Center
    Duke University Medical Center

    Durham, NC

    Key Differentiators

    • Oncology

  • #3

    University of Milan
    University of Milan

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #4

    European Institute of Oncology
    European Institute of Oncology

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

Original Source(s)

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

  • by Bassam Abdul Rasool Hassan, Ali Haider Mohammed, Khalis Mohamed, Vladimir Yu. Startsev, Chema Drira, Omar Hamdy, Miada Mohamed Fahmi Elmetwaly, Said Nabil, Shamma Alshehhi, Gamil Othman, Hamoud H. Y. Al-Hussaini, Ahmed Zuhair Abdulhameed Alsammarraie, Arooj Abid, Nada M. Kassem, Sami El Khatib, Souheil Hallit, Diana Malaeb, Hassan Hosseini

  • June 5, 2026

Related Content

Baseline 18F-FDG PET/CT habitat radiomics versus dual-channel deep learning for predicting interim PET early metabolic response in diffuse large B-cell lymphoma: a comparative study

Editorial: Autoantibodies in cancer: diagnostic, prognostic, and therapeutic potential

Lobectomy versus sublobar resection for stage I non-small cell lung cancer: an umbrella review of evidence quality, overlap, surgical-extent heterogeneity, and survival outcomes